INTRODUCTION:
Recently, 5-(indol-3-yl)-5-hydroxypyrimidine-2,4,6(1H, 3H,5H)-trione 1 was used as the precursor for the synthesis of the range of inhibitors of HAT enzymes [1] . These compounds find utility in any number of therapeutic applications, including treatment of cancer. Compound 1 was synthesized by the reaction of alloxan with indole in boiling ethanol solution in the presence of HCl (Scheme 1). 1 
Scheme 1.
Also, it was reported that alloxan hydrate condensed with 2-methylfurane in the presence of Sc(OTf)3 at room temperature in MeCN solution selectively forming 5-(5-methylfuran-2-yl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione 2 (Scheme 2).
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Scheme 2.
Compound 2 can be regarded as a precursor in the synthesis of 5-(5-methylfuran-2-yl)hydantoin. 1 It can be supposed that alloxan derivatives 1, 2 may be synthesized in simpler route. This work was undertaken to simplification of syntheses of these compounds and derivatives and to study their structure.
EXPERIMENTAL
1 Н spectra were recorded on VARIAN VXP-300 spectrometer (300 MHz) and VARIAN JEMINI 400 spectrometer (400 MHz); 13 С NMR spectra were recorded on VARIAN VXP-300 spectrometer (75 MHz) and VARIAN JEMINI 400 spectrometer (100 MHz), solvent: (CD3)2SO, with TMS as internal standard. Mass spectra were recorded on VG 70-70EQ mass spectrometer in fast atom bombardment (FAB) mode. The solvents were purified and dried according to standard procedures. MeOH was dried by distillation on Ca. Indole was purified by sublimation under vacuum (3 Hgmm Dimethylaniline, N,N-diethylaniline and N,Ndimetylhydrazone of 2-furylaldehyde were distillated under vacuum (2 Hgmm).
5-(Indol-3-yl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione (1)
A solution of 5,5-dihydroxypyrimidine-2,4,6(1H,3H,5H)-trione dihydrate (422 mg, 2.153 mmol) in MeOH (5 ml) was added to a solution of indole (252 mg, 2.153 mmol) ) in MeOH (5 ml), the reaction solution was kept at 20°С for 115 h, then solvent was evaporated under vacuum 4 Hgmm, the residue was stirred with PhH (10 ml), the solid was filtered out, dried under vacuum 20 Hgmm, then it was stirred with water (5 ml), the precipitate was filtered out and dried under vacuum 4 Hgmm, yielding (547 mg, 98 %) 5-(indol-3-yl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H , F(000) = 1552. Cell parameters and intensities of 41237 reflections (10952 independent reflections, Rint=0.043) were measured using "Xcalibur-3" diffractometer (T=293 K, graphitemonochromated MoK radiation, -scan, 2max= 60).
The structure was solved by direct method using the SHELXTL program package [5] . At structure refinement limitations were made on bond lengths in solvent molecules (Csp 3 -Csp 3 1.54 Å, Csp 3 -O 1.44 Å). Positions of the hydrogen atoms were located from electron density difference maps and refined using the riding model with Uiso = 1.2Ueqv of the carrier atom. The hydrogen atoms taking part in the formation of hydrogen bonds were refined in isotropic approximation.
Full-matrix least-squares refinement against F 2 in anisotropic approximation for nonhydrogen atoms using 10787 reflections was converged to wR2 = 0.276 (R1 = 0.086 for 4112 reflections with F>4(F), S=0.929). The final atomic coordinates, and crystallographic data for molecule 1 have been deposited to with the Cambridge Crystallographic Data Centre, 12 Union Road, CB2 1EZ, UK (fax: +44-1223-336033; e-mail: deposit@ccdc.cam.ac.uk) and are available on request quoting the deposition numbers CCDC 1538278)
5-(5-Methylfuran-2-yl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione (2)
The mixture of 5,5-dihydroxypyrimidine-2,4,6(1H,3H,5H)-trione dihydrate (215 mg, 1.005 mmol) and solution of 2-methtylfurane (287 mg, 3.499 mmol) in acetic acid (18 ml) was stirred at 23C for 143 h, then the solvent was evaporated under vacuum 4 Hgmm, the residue was washed by cold water (5 ml The i-PrOH filtrate was kept -22°С for 50 h, the formed precipitate was filtered off, washed by Et2O (3 ml), dried under vacuum 4 Hgmm, additionally yielding (82 mg, 13%) compound 3. The acetic acid filtrate was evaporated under vacuum 3 Hgmm, the residue washed by water (3 ml), dried under vacuum 3 Hgmm, additionally yielding (44 mg, 4.8%) compound 4a.
5-(4-N,N-Dimethylaminophenyl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione (4a)
5-(4-N,N-Diethylaminophenyl)-5-hydroxypyrimidine-2,4,6(1H, 3H,5H)-trione (4b)
The mixture of 5,5-dihydroxypyrimidine-2,4,6(1H,3H,5H)-trione dihydrate (1.56 g, 7.96 mmol), N,Ndiethylaniline (1.08 g, 7.237 mmol) and acetic acid (20 ml) was stirred at 20C for 70 h, the negligible precipitate was filtered off, the filtrate was evaporated under vacuum 3 Hgmm, the residue was washed a) by CH2Cl2 (15 ml), b) by cold water (25 ml), dried under vacuum 3 Hgmm, yielding 
RESULTS AND DISCUSSION
Independently we had found that 5-(indol-3-yl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione 1 could be synthesized with high yield by alloxan hydrate interaction with indole in methanol solution at room temperature (preliminary communications [3, 4] ). The structure of compound 1 has been proved by data of 1 H and 13 C NMR spectra and mass spectra. Earlier these data had been no reported [1] . Also the XRD study of 5-(indol-3-yl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione 1 has been done ( Figure 1) . The two from three solvate molecules of tetrahydrofuran are disordered over two twist conformations with equal population.
In the crystal molecules, А and В have a different supramolecular arrangement. Molecule A forms four intermolecular hydrogen bonds as the proton donor and three intermolecular hydrogen bonds as the proton acceptor. Molecule В forms four intermolecular hydrogen bonds as the proton donor and two intermolecular hydrogen bonds as the proton acceptor.
It was found that 5-(5-methylfuran-2-yl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione 2 formed with high yield in alloxan hydrate reaction with 2-methylfurane in acetic acid solution at room temperature. In this reaction Sc(OTf)3 presence is not need. The structure of compound 2 has been proved by data of 1 H and 13 C NMR spectra and mass spectra.
In the same manner, alloxane hydrate reacts with N,Ndimethylhydrazone of 2-furylaldehyde yielding 5-(5-N,Ndimethylhydrazonylfuran-2-yl)-5-hydroxypyrimidine-2,4,6 (1H,3H,5H)-trione 3 (Scheme 3). This reaction takes place in the acetic acid solution at room temperatures.
Scheme 3.
It was found that alloxane reacted with N,Ndimethylaniline and N,N-diethylaniline in acetic acid at room temperature yielding 5-(4-N,N-dimethylaminophenyl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione 4a and 5-(4-N,N-diethylaminophenyl)-5-hydroxypyrimidine-2,4,6(1H,3H,5H)-trione 4b, respectively (Scheme 4).
Scheme 4.
The structures of compounds 3, 4a, and 4b are consistent with the data of 1 H and 13 C NMR spectra and mass spectra. Compound 3, 4a, and 4b may be regard as precursors for the synthesis of respective hydantoins. 
Conclusions
